EC Healthcare (HKG:2138)

EC Healthcare Income Statement

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	4,153	4,211	3,875	2,920	2,080	1,949
Revenue	4,153	4,211	3,875	2,920	2,080	1,949
Revenue Growth (YoY)	1.20%	8.66%	32.74%	40.33%	6.77%	5.18%
Cost of Revenue	2,808	2,881	2,614	1,734	1,264	1,062
Gross Profit	1,345	1,330	1,261	1,185	816.04	886.41
Selling, General & Admin	603.99	599.48	560.33	426.8	322.2	217.32
Other Operating Expenses	-3.15	-3.78	-4.71	-5.42	-5.15	76.48
Operating Expenses	1,213	1,221	1,142	853.75	626.91	539.59
Operating Income	131.81	109.04	119.04	331.67	189.13	346.82
Interest Expense	-109.95	-100.84	-63.64	-48.91	-23.65	-18.06
Interest & Investment Income	21.35	17.22	4.87	1.36	1.71	1.12
Earnings From Equity Investments	2.91	5.43	12.33	-0.67	4.99	0.12
Currency Exchange Gain (Loss)	-	-	-	-	-	-1.07
Other Non Operating Income (Expenses)	38.22	36.93	32.72	18.54	8.27	16.27
EBT Excluding Unusual Items	84.34	67.78	105.33	301.99	180.45	345.19
Merger & Restructuring Charges	-0.48	-0.48	-0.28	-1.21	-1.02	-0.11
Impairment of Goodwill	-	-	-7.48	-	-	-
Gain (Loss) on Sale of Investments	-22.09	-24.58	-19.09	-11.57	-2.89	18.12
Gain (Loss) on Sale of Assets	0.47	-1.84	3.64	19.12	16.78	3.33
Asset Writedown	-26.38	-26.38	2.2	10.8	-2.7	-6
Other Unusual Items	2.37	2.37	51.88	2.28	75.28	-
Pretax Income	38.23	16.87	136.19	321.41	265.9	360.52
Income Tax Expense	3.67	1.18	29.16	50.91	40.3	50.25
Earnings From Continuing Operations	34.57	15.7	107.03	270.5	225.59	310.27
Minority Interest in Earnings	-46.07	-34.64	-37.37	-73	-32.73	-23.7
Net Income	-11.5	-18.95	69.65	197.5	192.87	286.58
Net Income to Common	-11.5	-18.95	69.65	197.5	192.87	286.58
Net Income Growth	-	-	-64.73%	2.40%	-32.70%	-20.64%
Shares Outstanding (Basic)	1,185	1,185	1,181	1,153	1,027	985
Shares Outstanding (Diluted)	1,185	1,185	1,184	1,173	1,031	988
Shares Change (YoY)	0.11%	0.08%	0.94%	13.79%	4.33%	0.18%
EPS (Basic)	-0.01	-0.02	0.06	0.17	0.19	0.29
EPS (Diluted)	-0.01	-0.02	0.06	0.17	0.19	0.29
EPS Growth	-	-	-64.88%	-10.16%	-35.52%	-20.77%
Free Cash Flow	632.09	527.88	194.27	348.09	484.94	506.7
Free Cash Flow Per Share	0.53	0.45	0.16	0.30	0.47	0.51
Dividend Per Share	0.010	0.005	0.100	0.144	0.159	0.230
Dividend Growth	-78.72%	-95.00%	-30.56%	-9.43%	-30.87%	100.00%
Gross Margin	32.38%	31.59%	32.55%	40.60%	39.23%	45.49%
Operating Margin	3.17%	2.59%	3.07%	11.36%	9.09%	17.80%
Profit Margin	-0.28%	-0.45%	1.80%	6.77%	9.27%	14.71%
Free Cash Flow Margin	15.22%	12.54%	5.01%	11.92%	23.31%	26.00%
EBITDA	428.83	393.23	352.13	497.07	304.37	429.73
EBITDA Margin	10.33%	9.34%	9.09%	17.03%	14.63%	22.05%
D&A For EBITDA	297.03	284.19	233.08	165.41	115.23	82.91
EBIT	131.81	109.04	119.04	331.67	189.13	346.82
EBIT Margin	3.17%	2.59%	3.07%	11.36%	9.09%	17.80%
Effective Tax Rate	9.60%	6.99%	21.41%	15.84%	15.16%	13.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.